N
Nicholas E. Diamant
Researcher at University of Toronto
Publications - 139
Citations - 9750
Nicholas E. Diamant is an academic researcher from University of Toronto. The author has contributed to research in topics: Esophagus & Swallowing. The author has an hindex of 47, co-authored 139 publications receiving 9161 citations. Previous affiliations of Nicholas E. Diamant include University Health Network & Queen's University.
Papers
More filters
Journal ArticleDOI
Dysphagia After Stroke Incidence, Diagnosis, and Pulmonary Complications
Rosemary Martino,Norine Foley,Sanjit K. Bhogal,Nicholas E. Diamant,Mark Speechley,Robert Teasell +5 more
TL;DR: The high incidence for dysphagia and pneumonia is a consistent finding with stroke patients, and the pneumonia risk is greatest in stroke patients with aspiration.
Journal ArticleDOI
Functional bowel disorders - A multicenter comparison of health status and development of illness severity index
Douglas A. Drossman,Zhiming Li,Brenda B. Toner,Nicholas E. Diamant,Francis Creed,David R. Thompson,Nicholas W. Read,Chris Babbs,Marcelo A. Barreiro,Leslie Bank,William E. Whitehead,Marvin M. Schuster,Elspeth Guthrie +12 more
TL;DR: The FBDSI can be used to select patients for research protocols and/or follow their clinical outcome or response to treatments over time to develop a functional bowel disorder severity index for research and clinical care.
Journal ArticleDOI
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders
Douglas A. Drossman,Brenda B. Toner,William E. Whitehead,Nicholas E. Diamant,Christine B. Dalton,Susan Duncan,Shelagh Emmott,Valerie Proffitt,Donna Akman,Karen Frusciante,Terry Le,Kim Meyer,Barbara H. Bradshaw,Kristi Mikula,Carolyn B. Morris,Carlar Blackman,Yuming Hu,Huanguang Jia,Jim Z. Li,Gary G. Koch,Shrikant I. Bangdiwala +20 more
TL;DR: In this article, the clinical efficacy and safety of cognitive-behavioral therapy (CBT) against education (EDU) and desipramine (DES) against placebo (PLA) in female patients with moderate to severe functional bowel disorders (irritable bowel syndrome, functional abdominal pain, painful constipation, and unspecified FBD).
Journal ArticleDOI
Cortical activation during human volitional swallowing: an event-related fMRI study.
Shaheen Hamdy,David J. Mikulis,Adrian P. Crawley,Shuwen Xue,Helena Lau,Stanley C. Henry,Nicholas E. Diamant +6 more
TL;DR: Activations were bilateral, but almost every region, particularly the premotor, insular, and frontal opercular cortices, displayed lateralization to one or the other hemisphere.
Journal ArticleDOI
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
Douglas A. Drossman,Donald L. Patrick,William E. Whitehead,Brenda B. Toner,Nicholas E. Diamant,Yuming Hu,Huanguang Jia,Shrikant I. Bangdiwala +7 more
TL;DR: The IBS-QOL is responsive to treatment in a referral-based clinical population of patients with functional bowel disorders, and there was a significant correlation between change scores on the IBS -QOL and the other measures of treatment effect.